Correspondence 0001493152-26-026698 from Serina Therapeutics, Inc. (SER)
Serina Therapeutics, Inc.
Date: June 1, 2026 · CIK: 0001708599 · Accession: 0001493152-26-026698
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-296166
Letter
Serina Therapeutics, Inc.
Genome Way, Suite 2001
Huntsville, AL 35806
(256) 327-0548
June 1, 2026
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
F Street, NE
Washington, D.C. 20549
Attention: Doris Stacey Gama
Re: Serina Therapeutics, Inc.
Registration Statement on Form S-3
File No. 333-296166
REQUEST FOR ACCELERATION OF EFFECTIVENESS
Requested Date: Wednesday, June 3, 2026
Requested Time: 4:30 p.m., Eastern Time
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, Serina Therapeutics, Inc., a Delaware corporation (the "Company"), respectfully requests that the effective date for the Registration Statement referred to above be accelerated so that it will become effective at 4:30 p.m., Eastern Time, on Wednesday, June 3, 2026, or as soon thereafter as is practicable.
Please contact Stephen Hinton of Bradley Arant Boult Cummings LLP, the Company's legal counsel, at (615) 252-3585, if you have any questions or concerns regarding this matter. Thank you in advance for your assistance.
Sincerely,
SERINA
THERAPEUTICS, INC.
Show Raw Text
CORRESP 1 filename1.htm Serina Therapeutics, Inc. 601 Genome Way, Suite 2001 Huntsville, AL 35806 (256) 327-0548 June 1, 2026 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, NE Washington, D.C. 20549 Attention: Doris Stacey Gama Re: Serina Therapeutics, Inc. Registration Statement on Form S-3 File No. 333-296166 REQUEST FOR ACCELERATION OF EFFECTIVENESS Requested Date: Wednesday, June 3, 2026 Requested Time: 4:30 p.m., Eastern Time Ladies and Gentlemen: In accordance with Rule 461 under the Securities Act of 1933, as amended, Serina Therapeutics, Inc., a Delaware corporation (the "Company"), respectfully requests that the effective date for the Registration Statement referred to above be accelerated so that it will become effective at 4:30 p.m., Eastern Time, on Wednesday, June 3, 2026, or as soon thereafter as is practicable. Please contact Stephen Hinton of Bradley Arant Boult Cummings LLP, the Company's legal counsel, at (615) 252-3585, if you have any questions or concerns regarding this matter. Thank you in advance for your assistance. Sincerely, SERINA THERAPEUTICS, INC. By: /s/ Steve Ledger Name: Steve Ledger Title: Chief Executive Officer cc: Stephen Hinton, Bradley Arant Boult Cummings LLP